Morgan Stanley

Morgan Stanley Chimes in on Celgene Corporation (CELG) Ahead of GED-0301 Topline Data

Morgan Stanley analyst Matthew Harrison provides commentary on Celgene Corporation (NASDAQ:CELG) ahead of topline data due for its pipeline oral Crohn’s drug GED-0301 …

Morgan Stanley Weighs In on Valeant Pharmaceuticals Intl Inc (VRX) and Amgen, Inc. (AMGN) Following Headquarter Visit and FDA CRL

Morgan Stanley analysts were out today with commentary on healthcare giants Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Amgen, Inc. (NASDAQ:AMGN).

Morgan Stanley Chimes In On Two Healthcare Giants: Valeant Pharmaceuticals Intl Inc (VRX), Biogen Inc (BIIB)

Healthcare analysts are weighing in on healthcare giants Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Biogen Inc (NASDAQ:BIIB). While one analyst becomes more bullish on Valeant as …

Morgan Stanley Weighs in on QUALCOMM, Inc. (QCOM) Following ‘Earnings Power Analysis’ Update

Morgan Stanley reduces peak earnings estimate for QUALCOMM to $6.28 from $6.

Morgan Stanley Bullish On Palo Alto Networks Inc (PANW) Ahead Of FQ4:16

Palo Alto Networks Inc (NYSE:PANW) entered its fiscal fourth-quarter “against very low expectations,” in the eyes of Morgan Stanley analyst Keith Weiss. Yet, …

Top Analyst’s Take on Cypress Semiconductor Corporation (CY) as CEO Transition Unfolds

Morgan Stanley top analyst Craig Hettenbach reiterates an Equal Weight rating on Cypress Semiconductor Corporation (NASDAQ:CY), as the company selected its second CEO in a long history of 34 …

Morgan Stanley Remains Cautious on Cisco Systems, Inc. (CSCO) Ahead of Fiscal 4Q Earnings

Morgan Stanley analyst James Faucette weighs in on shares of Cisco Systems, Inc. (NASDAQ:CSCO) ahead of fourth-quarter results.

Morgan Stanley Sings The Praises Of, Inc. (AMZN) Following AWS Summit

Yesterday, Morgan Stanley analyst Brian Nowak attended, Inc.

Morgan Stanley Weighs in on Endo International plc – Ordinary Shares (ENDP) Following Vasostrict Price Increase

Endo International plc – Ordinary Shares (NASDAQ:ENDP) just raised the price on its pipeline drug, Vasostrict, a polypeptide hormone indicated to increase blood …

Morgan Stanley Reiterates Overweight on QUALCOMM, Inc. (QCOM) Following New QTL Agreement With OPPO

Morgan Stanley analyst James Faucette reiterates an Overweight rating with a $65 price target on shares of QUALCOMM, Inc. (NASDAQ:QCOM), following the company’s latest …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts